Despite being a breakthrough drug in the treatment of Hepatitis C with an impressive cure rate (>90%), it is well known that Gilead has come under fire for the hefty price tag it has placed on Sovaldi.
Continue reading "Is Gilead’s Pricing of Breakthrough Hepatitis C Drugs Justified?"
At the height of President Richard Nixon’s war against drugs in 1970, he urged Congress to pass the Controlled Substances Act to crack down on drug abuse across the United States. This law categorizes controlled substances into five schedule groups, which are determined by their medical acceptance, abuse potential, and ability to produce dependence.
Continue reading "Should Federal Law Classify Cannabis As One of the Nation’s Most Dangerous Drugs?"
Opponents of pharmaceutical funding for clinical research claim that pharmaceutical companies have too much power to fuel truly ethical research to approve these drugs; however, without funding from the pharmaceutical industry, researchers simply do not have the financial resources to study the molecules that can potentially save lives.
Continue reading "Is It Ethical for Pharmaceutical Companies to Fund Clinical Research: Ebola as a Case Study Background"
In the midst of the recent Ebola scare in the United States, medical technology alumna Elizabeth Elliott MT’09 volunteered to run samples from Ebola patients in a biosafety laboratory at National Institutes of Health (NIH).
Continue reading "Medical Technology Alumna Honored by NIH for Ebola Care Efforts"
With hospitals and clinics scrambling to find enough primary care doctors to meet the demand of patient care from the Affordable Care Act, they are increasingly turning to an already short supply of physician assistants.
Continue reading "Return on Educational Investment: 5 Key Reasons to Consider Being a Physician Assistant "
Stay accountable to fitness goals by scheduling a physical exam before Jan. 1, says USciences professors Karin Richards and Joan Ward.
Continue reading "New Year’s Fitness Goals Should Start with a Trip to the Doc, Says USciences Profs"
Whether patients are getting medications, seeing a primary care provider, discharged from a hospital, or getting emergency care, they are being shifted between different health care providers. Transitions of care is an important aspect of healthcare because it allows smooth movement of patients from one setting to another. Transitioning from the hospital to home can be difficult for patients, potentially leading to readmission if the transition is not well coordinated. Kirkham conducted a retrospective cohort study in two acute care hospitals in the United States to see the effect of a collaborative pharmacist-hospital care transition care program on the likelihood...
Continue reading "Medication Adherence and Hospital Readmissions"
The Philadelphia College of Pharmacy at University of the Sciences announces a live APhA Pharmacy-Based Immunization Delivery Training Program on Wednesday, Jan. 28.
Continue reading "PCP Announces Live APhA Pharmacy-Based Immunization Delivery Training Program at USciences "
Dr. Eric Bing was the lecturer at the fifth annual Lois K. Cohen Endowed Lecture Series in Global Health at USciences on Thursday, Oct. 30.
Continue reading "Us and Them: Exploring Imaginary Borders with Dr. Eric G. Bing"
Depression is a mental disorder that has an unknown cause. There are many explanations for developing depression including genetic, biological, environmental, and psychological features. Signs and symptoms of depression vary from minimal to severe. Indication that someone may need medication to regulate his or her mood include the following symptoms: persistent sadness, hopelessness, fatigue, irritable mood, loss of interest, feelings of guilt, difficulty concentrating, insomnia, and suicidal thoughts. There are a variety of classes of medications used for depression, but they all need to be given an adequate trial of about twelve weeks to see if the medication is efficacious....
Continue reading "Medication Adherence In Patients with Depression"